Butt CM, Congleton J, Hoffman K, Fang M, Stapleton HM
This article explores what the evidence shows about semaglutide and headaches, why they may happen, and how PlexusDx patients manage this potential side effect
At the same time, the body may still be burning fewer calories following weight loss, making it easier to regain weight.[3][4] But research shows that weight regain is not inevitable
That early visibility window is sufficient to redirect biosimilar development investment toward a different reference product before sunk costs make the pivot expensive
Researchers suggest the drugs effects on blood sugar control, inflammation reduction, and vascular health may play a key role in improving heart outcomes
Wegovy, a higher dose version of the same drug, was approved for weight loss in 2021 in Canada but has never been sold here due to high global demand and supply shortages